CellCept® IV (mycophenolate mofetil) – First-time generic
November 22, 2016 – Par launched an AP-rated generic version of Genentech’s CellCept (mycophenolate mofetil) injection for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Download PDF
